Search

everythinglearnresearchcommunity

for

Search:↓

Post-COVID syndrome symptoms are common and overlap with general health issues.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

The document concludes that Passiflora incarnata could help with anxiety, telemedicine might improve heart failure care, screen time for kids has increased, pregnant teens in Brazil are mostly okay with their body image, rare tuberculosis infection can occur after knee surgery, older and severely ill people are more likely to have long COVID-19 symptoms, HPLC might diagnose more diabetes cases, and psychiatrists should be involved in pain management.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Skin symptoms like rashes and hives can help identify COVID-19 early.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Genetic differences affect how people respond to COVID-19.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Long COVID has severely affected a couple's health, finances, and social life.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Six existing drugs may help block virus entry in COVID-19.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Many people in Thailand have lingering symptoms after recovering from COVID-19.